nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—colon cancer	0.623	1	CbGaD
Sitagliptin—CYP2C8—Fluorouracil—colon cancer	0.0611	0.287	CbGbCtD
Sitagliptin—ABCB1—Irinotecan—colon cancer	0.0431	0.202	CbGbCtD
Sitagliptin—ABCB1—Vincristine—colon cancer	0.0377	0.177	CbGbCtD
Sitagliptin—CYP3A4—Irinotecan—colon cancer	0.0258	0.121	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—colon cancer	0.0228	0.107	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—colon cancer	0.0226	0.106	CbGbCtD
Sitagliptin—DPP4—blood vessel—colon cancer	0.00512	0.147	CbGeAlD
Sitagliptin—DPP4—embryo—colon cancer	0.00305	0.0878	CbGeAlD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CDX2—colon cancer	0.00296	0.274	CbGpPWpGaD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CDX2—colon cancer	0.00263	0.243	CbGpPWpGaD
Sitagliptin—DPP4—epithelium—colon cancer	0.00249	0.0716	CbGeAlD
Sitagliptin—DPP4—smooth muscle tissue—colon cancer	0.0024	0.069	CbGeAlD
Sitagliptin—DPP4—renal system—colon cancer	0.00231	0.0664	CbGeAlD
Sitagliptin—DPP4—lymphoid tissue—colon cancer	0.00192	0.0552	CbGeAlD
Sitagliptin—DPP4—digestive system—colon cancer	0.0019	0.0545	CbGeAlD
Sitagliptin—DPP4—bone marrow—colon cancer	0.00175	0.0502	CbGeAlD
Sitagliptin—DPP4—vagina—colon cancer	0.00167	0.0481	CbGeAlD
Sitagliptin—DPP4—liver—colon cancer	0.00141	0.0406	CbGeAlD
Sitagliptin—ABCB1—blood vessel—colon cancer	0.00118	0.034	CbGeAlD
Sitagliptin—CYP2C8—renal system—colon cancer	0.00111	0.032	CbGeAlD
Sitagliptin—DPP4—lymph node—colon cancer	0.00108	0.0311	CbGeAlD
Sitagliptin—DPP4—Peptide hormone metabolism—CDX2—colon cancer	0.000893	0.0825	CbGpPWpGaD
Sitagliptin—CYP2C8—vagina—colon cancer	0.000806	0.0232	CbGeAlD
Sitagliptin—CYP3A4—renal system—colon cancer	0.000754	0.0217	CbGeAlD
Sitagliptin—Pancreatitis—Irinotecan—colon cancer	0.000742	0.00629	CcSEcCtD
Sitagliptin—Erectile dysfunction—Vincristine—colon cancer	0.000715	0.00607	CcSEcCtD
Sitagliptin—ABCB1—embryo—colon cancer	0.000705	0.0203	CbGeAlD
Sitagliptin—Upper respiratory tract infection—Irinotecan—colon cancer	0.000703	0.00597	CcSEcCtD
Sitagliptin—Pneumonia—Vincristine—colon cancer	0.000697	0.00591	CcSEcCtD
Sitagliptin—Depression—Vincristine—colon cancer	0.00069	0.00586	CcSEcCtD
Sitagliptin—CYP2C8—liver—colon cancer	0.00068	0.0195	CbGeAlD
Sitagliptin—Neuropathy peripheral—Vincristine—colon cancer	0.000679	0.00576	CcSEcCtD
Sitagliptin—Pneumonia—Irinotecan—colon cancer	0.000678	0.00576	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000673	0.00571	CcSEcCtD
Sitagliptin—Renal failure—Irinotecan—colon cancer	0.000663	0.00563	CcSEcCtD
Sitagliptin—Gastroenteritis—Capecitabine—colon cancer	0.000661	0.00561	CcSEcCtD
Sitagliptin—Pneumonia—Fluorouracil—colon cancer	0.00065	0.00551	CcSEcCtD
Sitagliptin—Infestation NOS—Fluorouracil—colon cancer	0.000646	0.00548	CcSEcCtD
Sitagliptin—Infestation—Fluorouracil—colon cancer	0.000646	0.00548	CcSEcCtD
Sitagliptin—Renal failure acute—Capecitabine—colon cancer	0.000634	0.00538	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000633	0.00537	CcSEcCtD
Sitagliptin—Urinary tract infection—Fluorouracil—colon cancer	0.000628	0.00533	CcSEcCtD
Sitagliptin—Hypoaesthesia—Vincristine—colon cancer	0.000619	0.00525	CcSEcCtD
Sitagliptin—CYP3A4—digestive system—colon cancer	0.000618	0.0178	CbGeAlD
Sitagliptin—Renal impairment—Capecitabine—colon cancer	0.000615	0.00522	CcSEcCtD
Sitagliptin—Urinary tract disorder—Vincristine—colon cancer	0.000614	0.00521	CcSEcCtD
Sitagliptin—Connective tissue disorder—Vincristine—colon cancer	0.000611	0.00518	CcSEcCtD
Sitagliptin—Urethral disorder—Vincristine—colon cancer	0.000609	0.00517	CcSEcCtD
Sitagliptin—Sinusitis—Fluorouracil—colon cancer	0.000606	0.00514	CcSEcCtD
Sitagliptin—Connective tissue disorder—Irinotecan—colon cancer	0.000595	0.00505	CcSEcCtD
Sitagliptin—Osteoarthritis—Capecitabine—colon cancer	0.000586	0.00497	CcSEcCtD
Sitagliptin—Pain in extremity—Capecitabine—colon cancer	0.000586	0.00497	CcSEcCtD
Sitagliptin—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—CTNNB1—colon cancer	0.000583	0.0539	CbGpPWpGaD
Sitagliptin—Cardiac disorder—Vincristine—colon cancer	0.000577	0.0049	CcSEcCtD
Sitagliptin—Hypoaesthesia—Fluorouracil—colon cancer	0.000577	0.0049	CcSEcCtD
Sitagliptin—Migraine—Capecitabine—colon cancer	0.000577	0.00489	CcSEcCtD
Sitagliptin—Pharyngitis—Fluorouracil—colon cancer	0.000575	0.00488	CcSEcCtD
Sitagliptin—ABCB1—epithelium—colon cancer	0.000575	0.0165	CbGeAlD
Sitagliptin—Face oedema—Capecitabine—colon cancer	0.000565	0.0048	CcSEcCtD
Sitagliptin—Angiopathy—Vincristine—colon cancer	0.000564	0.00479	CcSEcCtD
Sitagliptin—Cardiac disorder—Irinotecan—colon cancer	0.000562	0.00477	CcSEcCtD
Sitagliptin—Mediastinal disorder—Vincristine—colon cancer	0.00056	0.00475	CcSEcCtD
Sitagliptin—Angiopathy—Irinotecan—colon cancer	0.000549	0.00466	CcSEcCtD
Sitagliptin—Blood creatinine increased—Capecitabine—colon cancer	0.000549	0.00466	CcSEcCtD
Sitagliptin—Immune system disorder—Irinotecan—colon cancer	0.000547	0.00464	CcSEcCtD
Sitagliptin—Mediastinal disorder—Irinotecan—colon cancer	0.000546	0.00463	CcSEcCtD
Sitagliptin—Mental disorder—Vincristine—colon cancer	0.000545	0.00462	CcSEcCtD
Sitagliptin—Abdominal pain upper—Capecitabine—colon cancer	0.000535	0.00454	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Capecitabine—colon cancer	0.000535	0.00454	CcSEcCtD
Sitagliptin—ABCB1—renal system—colon cancer	0.000533	0.0153	CbGeAlD
Sitagliptin—Breast disorder—Capecitabine—colon cancer	0.000529	0.00449	CcSEcCtD
Sitagliptin—Nasopharyngitis—Capecitabine—colon cancer	0.000524	0.00444	CcSEcCtD
Sitagliptin—Back pain—Vincristine—colon cancer	0.000523	0.00444	CcSEcCtD
Sitagliptin—Flatulence—Irinotecan—colon cancer	0.000519	0.00441	CcSEcCtD
Sitagliptin—DPP4—Incretin synthesis, secretion, and inactivation—CTNNB1—colon cancer	0.000519	0.0479	CbGpPWpGaD
Sitagliptin—Back pain—Irinotecan—colon cancer	0.00051	0.00433	CcSEcCtD
Sitagliptin—Muscle spasms—Irinotecan—colon cancer	0.000507	0.0043	CcSEcCtD
Sitagliptin—Influenza—Capecitabine—colon cancer	0.000506	0.0043	CcSEcCtD
Sitagliptin—Ill-defined disorder—Irinotecan—colon cancer	0.000489	0.00415	CcSEcCtD
Sitagliptin—Bronchitis—Capecitabine—colon cancer	0.000487	0.00413	CcSEcCtD
Sitagliptin—Vertigo—Vincristine—colon cancer	0.000486	0.00413	CcSEcCtD
Sitagliptin—Abdominal discomfort—Capecitabine—colon cancer	0.000485	0.00412	CcSEcCtD
Sitagliptin—Vision blurred—Fluorouracil—colon cancer	0.000476	0.00404	CcSEcCtD
Sitagliptin—Malaise—Irinotecan—colon cancer	0.000475	0.00403	CcSEcCtD
Sitagliptin—Vertigo—Irinotecan—colon cancer	0.000473	0.00402	CcSEcCtD
Sitagliptin—Renal failure acute—Methotrexate—colon cancer	0.000472	0.00401	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Capecitabine—colon cancer	0.00047	0.00399	CcSEcCtD
Sitagliptin—Hypertension—Vincristine—colon cancer	0.000467	0.00396	CcSEcCtD
Sitagliptin—Myalgia—Vincristine—colon cancer	0.000461	0.00391	CcSEcCtD
Sitagliptin—Weight increased—Capecitabine—colon cancer	0.000461	0.00391	CcSEcCtD
Sitagliptin—CYP3A4—liver—colon cancer	0.00046	0.0132	CbGeAlD
Sitagliptin—Cough—Irinotecan—colon cancer	0.00046	0.0039	CcSEcCtD
Sitagliptin—Hyperglycaemia—Capecitabine—colon cancer	0.000457	0.00388	CcSEcCtD
Sitagliptin—Hypertension—Irinotecan—colon cancer	0.000455	0.00386	CcSEcCtD
Sitagliptin—Pneumonia—Capecitabine—colon cancer	0.000454	0.00385	CcSEcCtD
Sitagliptin—Infestation NOS—Capecitabine—colon cancer	0.000451	0.00383	CcSEcCtD
Sitagliptin—Infestation—Capecitabine—colon cancer	0.000451	0.00383	CcSEcCtD
Sitagliptin—Depression—Capecitabine—colon cancer	0.00045	0.00382	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000447	0.0038	CcSEcCtD
Sitagliptin—Renal failure—Capecitabine—colon cancer	0.000444	0.00377	CcSEcCtD
Sitagliptin—Discomfort—Irinotecan—colon cancer	0.000443	0.00376	CcSEcCtD
Sitagliptin—ABCB1—lymphoid tissue—colon cancer	0.000443	0.0127	CbGeAlD
Sitagliptin—Neuropathy peripheral—Capecitabine—colon cancer	0.000442	0.00375	CcSEcCtD
Sitagliptin—Anaphylactic shock—Vincristine—colon cancer	0.000442	0.00375	CcSEcCtD
Sitagliptin—Infection—Vincristine—colon cancer	0.000439	0.00372	CcSEcCtD
Sitagliptin—Urinary tract infection—Capecitabine—colon cancer	0.000439	0.00372	CcSEcCtD
Sitagliptin—ABCB1—digestive system—colon cancer	0.000438	0.0126	CbGeAlD
Sitagliptin—Osteoarthritis—Methotrexate—colon cancer	0.000436	0.0037	CcSEcCtD
Sitagliptin—Nervous system disorder—Vincristine—colon cancer	0.000433	0.00368	CcSEcCtD
Sitagliptin—Anaphylactic shock—Irinotecan—colon cancer	0.00043	0.00365	CcSEcCtD
Sitagliptin—Myalgia—Fluorouracil—colon cancer	0.00043	0.00365	CcSEcCtD
Sitagliptin—Infection—Irinotecan—colon cancer	0.000427	0.00363	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Capecitabine—colon cancer	0.000427	0.00362	CcSEcCtD
Sitagliptin—Discomfort—Fluorouracil—colon cancer	0.000425	0.0036	CcSEcCtD
Sitagliptin—Nervous system disorder—Irinotecan—colon cancer	0.000422	0.00358	CcSEcCtD
Sitagliptin—Anaphylactic shock—Fluorouracil—colon cancer	0.000412	0.0035	CcSEcCtD
Sitagliptin—Infection—Fluorouracil—colon cancer	0.000409	0.00347	CcSEcCtD
Sitagliptin—Nervous system disorder—Fluorouracil—colon cancer	0.000404	0.00343	CcSEcCtD
Sitagliptin—ABCB1—bone marrow—colon cancer	0.000403	0.0116	CbGeAlD
Sitagliptin—Hypoaesthesia—Capecitabine—colon cancer	0.000403	0.00342	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000402	0.00341	CcSEcCtD
Sitagliptin—Pharyngitis—Capecitabine—colon cancer	0.000402	0.00341	CcSEcCtD
Sitagliptin—Urinary tract disorder—Capecitabine—colon cancer	0.0004	0.0034	CcSEcCtD
Sitagliptin—Insomnia—Vincristine—colon cancer	0.000399	0.00339	CcSEcCtD
Sitagliptin—Oedema peripheral—Capecitabine—colon cancer	0.000399	0.00339	CcSEcCtD
Sitagliptin—Connective tissue disorder—Capecitabine—colon cancer	0.000398	0.00338	CcSEcCtD
Sitagliptin—Urethral disorder—Capecitabine—colon cancer	0.000397	0.00337	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—colon cancer	0.000394	0.00334	CcSEcCtD
Sitagliptin—Insomnia—Irinotecan—colon cancer	0.000389	0.0033	CcSEcCtD
Sitagliptin—ABCB1—vagina—colon cancer	0.000386	0.0111	CbGeAlD
Sitagliptin—Decreased appetite—Vincristine—colon cancer	0.000384	0.00326	CcSEcCtD
Sitagliptin—Erythema multiforme—Capecitabine—colon cancer	0.000383	0.00325	CcSEcCtD
Sitagliptin—Somnolence—Irinotecan—colon cancer	0.000382	0.00324	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—colon cancer	0.000381	0.00324	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—colon cancer	0.000381	0.00323	CcSEcCtD
Sitagliptin—Eye disorder—Capecitabine—colon cancer	0.000379	0.00321	CcSEcCtD
Sitagliptin—Dyspepsia—Irinotecan—colon cancer	0.000379	0.00321	CcSEcCtD
Sitagliptin—Pain—Vincristine—colon cancer	0.000378	0.0032	CcSEcCtD
Sitagliptin—Constipation—Vincristine—colon cancer	0.000378	0.0032	CcSEcCtD
Sitagliptin—Cardiac disorder—Capecitabine—colon cancer	0.000376	0.00319	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000375	0.00318	CcSEcCtD
Sitagliptin—Decreased appetite—Irinotecan—colon cancer	0.000374	0.00317	CcSEcCtD
Sitagliptin—Insomnia—Fluorouracil—colon cancer	0.000373	0.00316	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000371	0.00315	CcSEcCtD
Sitagliptin—Fatigue—Irinotecan—colon cancer	0.000371	0.00315	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—colon cancer	0.000369	0.00314	CcSEcCtD
Sitagliptin—Constipation—Irinotecan—colon cancer	0.000368	0.00312	CcSEcCtD
Sitagliptin—Pain—Irinotecan—colon cancer	0.000368	0.00312	CcSEcCtD
Sitagliptin—Angiopathy—Capecitabine—colon cancer	0.000368	0.00312	CcSEcCtD
Sitagliptin—Somnolence—Fluorouracil—colon cancer	0.000366	0.00311	CcSEcCtD
Sitagliptin—Immune system disorder—Capecitabine—colon cancer	0.000366	0.00311	CcSEcCtD
Sitagliptin—Mediastinal disorder—Capecitabine—colon cancer	0.000365	0.0031	CcSEcCtD
Sitagliptin—Dyspepsia—Fluorouracil—colon cancer	0.000363	0.00308	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—colon cancer	0.000361	0.00307	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—colon cancer	0.000361	0.00306	CcSEcCtD
Sitagliptin—Decreased appetite—Fluorouracil—colon cancer	0.000358	0.00304	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000356	0.00302	CcSEcCtD
Sitagliptin—Mental disorder—Capecitabine—colon cancer	0.000355	0.00301	CcSEcCtD
Sitagliptin—Feeling abnormal—Irinotecan—colon cancer	0.000354	0.00301	CcSEcCtD
Sitagliptin—Malnutrition—Capecitabine—colon cancer	0.000353	0.00299	CcSEcCtD
Sitagliptin—Pain—Fluorouracil—colon cancer	0.000352	0.00299	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Irinotecan—colon cancer	0.000352	0.00298	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—colon cancer	0.00035	0.00297	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—colon cancer	0.000349	0.00296	CcSEcCtD
Sitagliptin—Flatulence—Capecitabine—colon cancer	0.000348	0.00295	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—colon cancer	0.000347	0.00295	CcSEcCtD
Sitagliptin—Back pain—Capecitabine—colon cancer	0.000341	0.0029	CcSEcCtD
Sitagliptin—Abdominal pain—Irinotecan—colon cancer	0.00034	0.00289	CcSEcCtD
Sitagliptin—Feeling abnormal—Fluorouracil—colon cancer	0.000339	0.00288	CcSEcCtD
Sitagliptin—Muscle spasms—Capecitabine—colon cancer	0.000339	0.00288	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—colon cancer	0.000338	0.00287	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—colon cancer	0.000336	0.00285	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—colon cancer	0.000336	0.00285	CcSEcCtD
Sitagliptin—Depression—Methotrexate—colon cancer	0.000335	0.00284	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000333	0.00283	CcSEcCtD
Sitagliptin—Vision blurred—Capecitabine—colon cancer	0.000332	0.00282	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—colon cancer	0.00033	0.0028	CcSEcCtD
Sitagliptin—Ill-defined disorder—Capecitabine—colon cancer	0.000327	0.00278	CcSEcCtD
Sitagliptin—Urticaria—Fluorouracil—colon cancer	0.000327	0.00278	CcSEcCtD
Sitagliptin—ABCB1—liver—colon cancer	0.000326	0.00937	CbGeAlD
Sitagliptin—Hypersensitivity—Vincristine—colon cancer	0.000325	0.00276	CcSEcCtD
Sitagliptin—Malaise—Capecitabine—colon cancer	0.000318	0.0027	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—colon cancer	0.000318	0.0027	CcSEcCtD
Sitagliptin—CYP2C8—Metapathway biotransformation—CHST4—colon cancer	0.000318	0.0293	CbGpPWpGaD
Sitagliptin—Vertigo—Capecitabine—colon cancer	0.000317	0.00269	CcSEcCtD
Sitagliptin—Hypersensitivity—Irinotecan—colon cancer	0.000317	0.00269	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—colon cancer	0.000317	0.00269	CcSEcCtD
Sitagliptin—Asthenia—Irinotecan—colon cancer	0.000309	0.00262	CcSEcCtD
Sitagliptin—Cough—Capecitabine—colon cancer	0.000308	0.00261	CcSEcCtD
Sitagliptin—Hypertension—Capecitabine—colon cancer	0.000305	0.00258	CcSEcCtD
Sitagliptin—Hypersensitivity—Fluorouracil—colon cancer	0.000304	0.00258	CcSEcCtD
Sitagliptin—Diarrhoea—Vincristine—colon cancer	0.000302	0.00256	CcSEcCtD
Sitagliptin—Arthralgia—Capecitabine—colon cancer	0.0003	0.00255	CcSEcCtD
Sitagliptin—Myalgia—Capecitabine—colon cancer	0.0003	0.00255	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—colon cancer	0.000299	0.00254	CcSEcCtD
Sitagliptin—Anxiety—Capecitabine—colon cancer	0.000299	0.00254	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000298	0.00253	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—colon cancer	0.000298	0.00253	CcSEcCtD
Sitagliptin—Discomfort—Capecitabine—colon cancer	0.000297	0.00252	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—colon cancer	0.000296	0.00251	CcSEcCtD
Sitagliptin—Diarrhoea—Irinotecan—colon cancer	0.000294	0.0025	CcSEcCtD
Sitagliptin—Dry mouth—Capecitabine—colon cancer	0.000294	0.00249	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—colon cancer	0.000292	0.00248	CcSEcCtD
Sitagliptin—Infection—Capecitabine—colon cancer	0.000286	0.00243	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—colon cancer	0.000285	0.00242	CcSEcCtD
Sitagliptin—Dizziness—Irinotecan—colon cancer	0.000284	0.00241	CcSEcCtD
Sitagliptin—Nervous system disorder—Capecitabine—colon cancer	0.000282	0.0024	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—colon cancer	0.000282	0.00239	CcSEcCtD
Sitagliptin—Diarrhoea—Fluorouracil—colon cancer	0.000282	0.00239	CcSEcCtD
Sitagliptin—Vomiting—Vincristine—colon cancer	0.000281	0.00238	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—colon cancer	0.00028	0.00238	CcSEcCtD
Sitagliptin—Skin disorder—Capecitabine—colon cancer	0.00028	0.00237	CcSEcCtD
Sitagliptin—Rash—Vincristine—colon cancer	0.000278	0.00236	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—colon cancer	0.000278	0.00236	CcSEcCtD
Sitagliptin—Headache—Vincristine—colon cancer	0.000277	0.00235	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—colon cancer	0.000274	0.00232	CcSEcCtD
Sitagliptin—Vomiting—Irinotecan—colon cancer	0.000273	0.00232	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—colon cancer	0.000272	0.00231	CcSEcCtD
Sitagliptin—Dizziness—Fluorouracil—colon cancer	0.000272	0.00231	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—colon cancer	0.000272	0.00231	CcSEcCtD
Sitagliptin—Rash—Irinotecan—colon cancer	0.000271	0.0023	CcSEcCtD
Sitagliptin—Dermatitis—Irinotecan—colon cancer	0.000271	0.0023	CcSEcCtD
Sitagliptin—Headache—Irinotecan—colon cancer	0.000269	0.00229	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—colon cancer	0.000264	0.00224	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—colon cancer	0.000263	0.00223	CcSEcCtD
Sitagliptin—Nausea—Vincristine—colon cancer	0.000262	0.00223	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000262	0.00223	CcSEcCtD
Sitagliptin—Vomiting—Fluorouracil—colon cancer	0.000262	0.00222	CcSEcCtD
Sitagliptin—Insomnia—Capecitabine—colon cancer	0.00026	0.00221	CcSEcCtD
Sitagliptin—Rash—Fluorouracil—colon cancer	0.00026	0.0022	CcSEcCtD
Sitagliptin—Dermatitis—Fluorouracil—colon cancer	0.000259	0.0022	CcSEcCtD
Sitagliptin—Headache—Fluorouracil—colon cancer	0.000258	0.00219	CcSEcCtD
Sitagliptin—Nausea—Irinotecan—colon cancer	0.000255	0.00217	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—colon cancer	0.000254	0.00216	CcSEcCtD
Sitagliptin—Dyspepsia—Capecitabine—colon cancer	0.000253	0.00215	CcSEcCtD
Sitagliptin—Decreased appetite—Capecitabine—colon cancer	0.00025	0.00212	CcSEcCtD
Sitagliptin—ABCB1—lymph node—colon cancer	0.00025	0.00719	CbGeAlD
Sitagliptin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000249	0.00211	CcSEcCtD
Sitagliptin—Fatigue—Capecitabine—colon cancer	0.000248	0.00211	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—colon cancer	0.000247	0.0021	CcSEcCtD
Sitagliptin—Constipation—Capecitabine—colon cancer	0.000246	0.00209	CcSEcCtD
Sitagliptin—Pain—Capecitabine—colon cancer	0.000246	0.00209	CcSEcCtD
Sitagliptin—Nausea—Fluorouracil—colon cancer	0.000245	0.00208	CcSEcCtD
Sitagliptin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000244	0.0225	CbGpPWpGaD
Sitagliptin—Ill-defined disorder—Methotrexate—colon cancer	0.000244	0.00207	CcSEcCtD
Sitagliptin—Feeling abnormal—Capecitabine—colon cancer	0.000237	0.00201	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—colon cancer	0.000237	0.00201	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—colon cancer	0.000236	0.002	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Capecitabine—colon cancer	0.000235	0.002	CcSEcCtD
Sitagliptin—Cough—Methotrexate—colon cancer	0.000229	0.00194	CcSEcCtD
Sitagliptin—Urticaria—Capecitabine—colon cancer	0.000229	0.00194	CcSEcCtD
Sitagliptin—Abdominal pain—Capecitabine—colon cancer	0.000228	0.00193	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—colon cancer	0.000224	0.0019	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—colon cancer	0.000224	0.0019	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000222	0.00188	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—colon cancer	0.000221	0.00187	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—colon cancer	0.000214	0.00182	CcSEcCtD
Sitagliptin—Infection—Methotrexate—colon cancer	0.000213	0.00181	CcSEcCtD
Sitagliptin—Hypersensitivity—Capecitabine—colon cancer	0.000212	0.0018	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—colon cancer	0.00021	0.00178	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—colon cancer	0.000208	0.00177	CcSEcCtD
Sitagliptin—Asthenia—Capecitabine—colon cancer	0.000207	0.00175	CcSEcCtD
Sitagliptin—Diarrhoea—Capecitabine—colon cancer	0.000197	0.00167	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000195	0.00166	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—colon cancer	0.000194	0.00164	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—colon cancer	0.000191	0.00162	CcSEcCtD
Sitagliptin—Dizziness—Capecitabine—colon cancer	0.00019	0.00162	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—colon cancer	0.000189	0.0016	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—colon cancer	0.000186	0.00158	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000185	0.00157	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—colon cancer	0.000185	0.00157	CcSEcCtD
Sitagliptin—Pain—Methotrexate—colon cancer	0.000183	0.00156	CcSEcCtD
Sitagliptin—Vomiting—Capecitabine—colon cancer	0.000183	0.00155	CcSEcCtD
Sitagliptin—Rash—Capecitabine—colon cancer	0.000182	0.00154	CcSEcCtD
Sitagliptin—Dermatitis—Capecitabine—colon cancer	0.000181	0.00154	CcSEcCtD
Sitagliptin—Headache—Capecitabine—colon cancer	0.00018	0.00153	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—colon cancer	0.000177	0.0015	CcSEcCtD
Sitagliptin—DPP4—Peptide hormone metabolism—CTNNB1—colon cancer	0.000176	0.0163	CbGpPWpGaD
Sitagliptin—Gastrointestinal pain—Methotrexate—colon cancer	0.000175	0.00149	CcSEcCtD
Sitagliptin—Nausea—Capecitabine—colon cancer	0.000171	0.00145	CcSEcCtD
Sitagliptin—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00017	0.0157	CbGpPWpGaD
Sitagliptin—Urticaria—Methotrexate—colon cancer	0.00017	0.00144	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—colon cancer	0.000169	0.00144	CcSEcCtD
Sitagliptin—DPP4—Metabolism of proteins—CDX2—colon cancer	0.000169	0.0156	CbGpPWpGaD
Sitagliptin—Hypersensitivity—Methotrexate—colon cancer	0.000158	0.00134	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—colon cancer	0.000154	0.0013	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—colon cancer	0.000147	0.00124	CcSEcCtD
Sitagliptin—CYP2C8—Metapathway biotransformation—CHST5—colon cancer	0.000146	0.0135	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—MUC2—colon cancer	0.000143	0.0132	CbGpPWpGaD
Sitagliptin—Dizziness—Methotrexate—colon cancer	0.000142	0.0012	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—colon cancer	0.000136	0.00116	CcSEcCtD
Sitagliptin—Rash—Methotrexate—colon cancer	0.000135	0.00115	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—colon cancer	0.000135	0.00115	CcSEcCtD
Sitagliptin—Headache—Methotrexate—colon cancer	0.000134	0.00114	CcSEcCtD
Sitagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000134	0.0123	CbGpPWpGaD
Sitagliptin—Nausea—Methotrexate—colon cancer	0.000127	0.00108	CcSEcCtD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000117	0.0108	CbGpPWpGaD
Sitagliptin—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000112	0.0104	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	8.73e-05	0.00807	CbGpPWpGaD
Sitagliptin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.66e-05	0.008	CbGpPWpGaD
Sitagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	8.05e-05	0.00744	CbGpPWpGaD
Sitagliptin—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	7.83e-05	0.00723	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	7.67e-05	0.00709	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	5.96e-05	0.0055	CbGpPWpGaD
Sitagliptin—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	5.74e-05	0.00531	CbGpPWpGaD
Sitagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.34e-05	0.00493	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.01e-05	0.00463	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CA7—colon cancer	4.17e-05	0.00385	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.01e-05	0.0037	CbGpPWpGaD
Sitagliptin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	3.69e-05	0.00341	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CA7—colon cancer	3.64e-05	0.00336	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	3.33e-05	0.00308	CbGpPWpGaD
Sitagliptin—DPP4—Metabolism of proteins—CTNNB1—colon cancer	3.32e-05	0.00307	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—CASP3—colon cancer	3.22e-05	0.00298	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	3.16e-05	0.00292	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	3.07e-05	0.00284	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	2.96e-05	0.00274	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—VEGFA—colon cancer	2.73e-05	0.00253	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ODC1—colon cancer	2.53e-05	0.00234	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—CHST5—colon cancer	2.53e-05	0.00234	CbGpPWpGaD
Sitagliptin—ABCB1—Allograft Rejection—TGFB1—colon cancer	2.51e-05	0.00232	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.26e-05	0.00208	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CA7—colon cancer	2.24e-05	0.00207	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—CHST5—colon cancer	2.2e-05	0.00203	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—ODC1—colon cancer	2.2e-05	0.00203	CbGpPWpGaD
Sitagliptin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.01e-05	0.00186	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.71e-05	0.00158	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.59e-05	0.00147	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.55e-05	0.00143	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.53e-05	0.00142	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.5e-05	0.00138	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.42e-05	0.00132	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.39e-05	0.00128	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ODC1—colon cancer	1.36e-05	0.00125	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—CHST5—colon cancer	1.36e-05	0.00125	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.35e-05	0.00125	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.24e-05	0.00115	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.24e-05	0.00114	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.21e-05	0.00112	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.15e-05	0.00106	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.05e-05	0.000973	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.04e-05	0.000964	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.02e-05	0.000942	CbGpPWpGaD
Sitagliptin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.61e-06	0.000795	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.21e-06	0.000758	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.83e-06	0.000631	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—ABCB1—colon cancer	6.68e-06	0.000617	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—TYMS—colon cancer	6.56e-06	0.000606	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—TYMS—colon cancer	5.72e-06	0.000528	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.05e-06	0.000467	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PPARG—colon cancer	4.65e-06	0.000429	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PPARG—colon cancer	4.05e-06	0.000374	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PTGS2—colon cancer	3.66e-06	0.000338	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—ABCB1—colon cancer	3.59e-06	0.000331	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—TYMS—colon cancer	3.52e-06	0.000325	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PTGS2—colon cancer	3.19e-06	0.000294	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—EP300—colon cancer	3.04e-06	0.000281	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—EP300—colon cancer	2.65e-06	0.000245	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PPARG—colon cancer	2.49e-06	0.00023	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—PIK3CA—colon cancer	2.25e-06	0.000208	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PTGS2—colon cancer	1.96e-06	0.000181	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—PIK3CA—colon cancer	1.96e-06	0.000181	CbGpPWpGaD
Sitagliptin—CYP2C8—Metabolism—AKT1—colon cancer	1.84e-06	0.00017	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—EP300—colon cancer	1.63e-06	0.000151	CbGpPWpGaD
Sitagliptin—ABCB1—Metabolism—AKT1—colon cancer	1.6e-06	0.000148	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.21e-06	0.000112	CbGpPWpGaD
Sitagliptin—CYP3A4—Metabolism—AKT1—colon cancer	9.86e-07	9.11e-05	CbGpPWpGaD
